BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Testicular cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Prognosis
181 results:

  • 1. Genomic landscape and distinct molecular subtypes of primary testicular lymphoma.
    Zhang W; Yang P; Yang Y; Liu S; Xu Y; Wu C; Wang J; Liu C; Liu H; Li S; Huang W; Jing H
    J Transl Med; 2024 May; 22(1):414. PubMed ID: 38693538
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Epidemiology, Management, and Survival Outcomes of Germ Cell cancer in Southern Portugal: A Population-Based Study (2008-2012).
    Brito M; Ramos M; Silva JP; Câmara G; Mayer A; Miranda A; Coelho JLP; Moreira A; Esteves S
    Clin Genitourin Cancer; 2024 Feb; 22(1):e170-e177.e1. PubMed ID: 38061978
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Dose comparison of robustly optimized intensity modulated proton therapy (IMPT) vs IMRT and VMAT photon plans for testicular seminoma.
    Rønde HS; Kronborg C; Høyer M; Hansen J; Bak ME; Agergaard SN; Als AB; Agerbæk M; Lauritsen J; Meidahl Petersen P; Dysager L; Kallehauge JF
    Acta Oncol; 2023 Oct; 62(10):1222-1229. PubMed ID: 37683054
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Clinicopathologic characteristics and prognostic analysis of testicular diffuse large B-cell lymphoma].
    Wang Y; Shi ZY; Shi Q; Wang S; Zhang MC; Shen R; He Y; Qiu HL; Yi HM; Dong L; Wang L; Cheng S; Xu PP; Zhao WL
    Zhonghua Xue Ye Xue Za Zhi; 2023 Apr; 44(4):321-327. PubMed ID: 37357002
    [No Abstract]    [Full Text] [Related]  

  • 5. Primary Mediastinal Germ Cell Tumors (PMGCT): A Real-world Analysis From A Tertiary cancer Care Center in India.
    Sharma A; Reddy R; Pramanik R; Sahoo RK; Kaushal S; Haresh KP; Kumar S; Kumar L; Sharma A; Batra A
    Cancer Invest; 2023 May; 41(5):467-473. PubMed ID: 36927242
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Effects of deficient mismatch repair on the prognosis of patients with stage II and stage III colon cancer during different postoperative periods.
    Zhang C; Zhan Y; Ni K; Liu Z; Xin R; Han Q; Li G; Ping H; Liu Y; Zhao X; Wang W; Yan S; Sun J; Zhang Q; Wang G; Zhang Z; Zhang X; Hu X
    BMC Cancer; 2022 Nov; 22(1):1156. PubMed ID: 36352365
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. TP53 Alterations Are Associated With Poor Survival in Patients With Primary Mediastinal Nonseminoma Germ Cell Tumors.
    Bacon JVW; Giannatempo P; Cataldo G; Fazli L; Saxena N; Ozgun G; Soleimani M; Chi K; Nichols C; Necchi A; Wyatt AW; Kollmannsberger CK; Nappi L
    Oncologist; 2022 Nov; 27(11):e912-e915. PubMed ID: 36166584
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Laparoscopic retroperitoneal lymph-node dissection in metastatic nonseminomatous germ-cell tumors.
    Nazzani S; Stagni S; Biasoni D; Catanzaro M; Macchi A; Tesone A; Torelli T; Darisi R; Lo Russo V; Colbacchini C; Lanocita R; Cascella T; Claps M; Giannatempo P; Zimatore M; Cattaneo L; Montanari E; Salvioni R; Nicolai N
    Eur J Surg Oncol; 2023 Jan; 49(1):257-262. PubMed ID: 36031470
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Analytical Validation and Performance Characteristics of Molecular Serum Biomarkers, miR-371a-3p and miR-372-3p, for Male Germ Cell Tumors, in a Clinical Laboratory Setting.
    Ye F; Feldman DR; Valentino A; So R; Bromberg M; Khan S; Funt SA; Sheinfeld J; Solit DB; Pessin MS; Peerschke EI
    J Mol Diagn; 2022 Aug; 24(8):867-877. PubMed ID: 35934321
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Poor treatment responses were related to poor outcomes in pediatric B cell acute lymphoblastic leukemia with KMT2A rearrangements.
    Wen J; Zhou M; Shen Y; Long Y; Guo Y; Song L; Xiao J
    BMC Cancer; 2022 Aug; 22(1):859. PubMed ID: 35933338
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Phase II study of Disulfiram and Cisplatin in Refractory Germ Cell Tumors. The GCT-SK-006 phase II trial.
    Mego M; Svetlovska D; Angelis V D; Kalavska K; Lesko P; Makovník M; Obertova J; Orszaghova Z; Palacka P; Rečková M; Rejlekova K; Z SM; Mardiak J; Chovanec M
    Invest New Drugs; 2022 Oct; 40(5):1080-1086. PubMed ID: 35763178
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Differential expression of preferentially expressed antigen in melanoma (PRAME) in testicular germ cell tumors - A comparative study with SOX17.
    Zhou Y; Rothrock A; Murugan P; Li F; Bu L
    Exp Mol Pathol; 2022 Jun; 126():104761. PubMed ID: 35390309
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Chemoradiotherapy is an alternative choice for patients with primary mediastinal seminoma.
    Zhai Y; Chen B; Feng X; Liu K; Wang S; Hui Z; Feng Q; Li J; Xiao Z; Lv J; Gao Y; Liu Y; Fang H; Wang J; Deng L; Liu W; Wang W; Zhou Z; Li YX
    Radiat Oncol; 2022 Mar; 17(1):58. PubMed ID: 35346279
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A 10-year retrospective single-center study of alpha-fetoprotein and beta-human chorionic gonadotropin in Romanian children with (para)gonadal tumors and cysts.
    Ataikiru UO; Iacob ER; Miron I; Popoiu CM; Boia ES
    J Pediatr Endocrinol Metab; 2022 Mar; 35(3):363-371. PubMed ID: 34968016
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Clinical analysis of testicular rhabdomyosarcoma].
    Ye JF; Zhao L; Wang GL; Hong K; Ma LL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1178-1182. PubMed ID: 34916701
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Characteristics and outcomes analysis of ovarian Sertoli-Leydig cell tumors (SLCTs): analysis of 15 patients.
    Wang G; Zhang R; Li C; Chen A
    J Ovarian Res; 2021 Nov; 14(1):150. PubMed ID: 34736487
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. 12p gain is predominantly observed in non-germinomatous germ cell tumors and identifies an unfavorable subgroup of central nervous system germ cell tumors.
    Satomi K; Takami H; Fukushima S; Yamashita S; Matsushita Y; Nakazato Y; Suzuki T; Tanaka S; Mukasa A; Saito N; Kanamori M; Kumabe T; Tominaga T; Kobayashi K; Nagane M; Iuchi T; Yoshimoto K; Tamura K; Maehara T; Sakai K; Sugiyama K; Yokogami K; Takeshima H; Nonaka M; Asai A; Ushijima T; Matsutani M; Nishikawa R; Ichimura K
    Neuro Oncol; 2022 May; 24(5):834-846. PubMed ID: 34698864
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Perceived Positive and Negative Life Changes in testicular cancer Survivors.
    Vehling S; Oechsle K; Hartmann M; Bokemeyer C; Mehnert-Theuerkauf A
    Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577916
    [No Abstract]    [Full Text] [Related]  

  • 19. Primary mediastinal germ cell tumours with high prevalence of somatic malignancy: An experience from a single tertiary care oncology centre.
    Beg A; Kumar R; Sahay A; Janu A; Joshi A; Noronha V; Prabhash K; Karimundackal G; Jiwnani S; Agarwal JP; Pramesh CS
    Ann Diagn Pathol; 2021 Aug; 53():151763. PubMed ID: 34111707
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Comparison of the Prognostic Outcome between High-Grade Ovarian Sertoli-Leydig Cell Tumors (SLCTs) and Low-Grade SLCTs.
    Eoh KJ; Park J; Kim HM; Lee M; Kim YT
    Yonsei Med J; 2021 Apr; 62(4):366-369. PubMed ID: 33779091
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 10.